Cytosorbents (CTSO)
(Delayed Data from NSDQ)
$0.84 USD
-0.02 (-2.76%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $0.85 +0.01 (1.05%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Cytosorbents Corporation [CTSO]
Reports for Purchase
Showing records 21 - 40 ( 185 total )
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: The Canadians Are In Seven Sites For STAR-T
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
Looking to STAR-T Results in 2023; Continued Commercial Headwinds; Lower $5.50 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: Keep Your Eye on the Ball- The Story was Never About this Quarter
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
CytoSorb COVID-19 Registry Shows Favorable Survival; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: US Army Makes a $4.2M Bet on HemoDefend
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
New Manufacturing Facility Receives ISO Certification; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: Shalom Israel -CytoSorb Gets National Coverage
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: Reports 2nd Quarter Signs Global Marketing Agreement with Fresenius
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
Looking for Recovery in 2H22; New Facility Online; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Cytosorbents Corporation
Industry: Medical - Products
Continued Headwinds to Impact Near-term Revenues; Lower $9 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: Focus on the Clinic - The U.S. is in the Works
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
First Patient Enrolled in DrugSorb-STAR-D Trial
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
Pandemic Headwinds Ease; Expect Strong Growth in Core Indications; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: Reports a Strong Quarter- Clinical Events Ahead
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Cytosorbents Corporation
Industry: Medical - Products
BUY: Dear Shareholders - We Spoke to Management
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J